The funds will help the company’s commercial expansion for the BEAR implant and clinical activities for it, according to a news release. The BEAR implant, which uses a patient’s blood to help treat ACL tears, has been used in nearly 3,000 patients.
The Major League Soccer Players Association, SV Health Investors and Aperture Venture Partners joined existing investors for the funding.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
